Cell type specific and inducible promoters for vectors in gene therapy as an approach for cell targeting

Journal of Molecular Medicine

Volumn 74, Issue 7, 1996, Pages 379-392

  Walther, W ^a   Stein, U ^a  

^a MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

Author keywords

Cell type specific; Gene therapy; Promoter; Targeting; Viral expression vectors

Indexed keywords

CELL SPECIFICITY; ENHANCER REGION; EXPRESSION VECTOR; GENE EXPRESSION REGULATION; GENE TARGETING; GENE THERAPY; GENE TRANSFER; HUMAN; NONHUMAN; PROMOTER REGION; REVIEW; VIRUS EXPRESSION;

EID: 0029743139     PISSN: 09462716     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF00210632     Document Type: Review

References (82)

1. Agura ED, Howard M, Collins SJ (1992) Identification and sequence analysis of the promoter for the leukocyte integrin beta subunit (CD18): a retinoic acid inducible gene. Blood 79:602-609
2. Anderson WF (1992) Human gene therapy. Science 256:808-813
3. Apperley JF (1993) Bone marrow transplant for the haemoglobinopathies: past, present and future. Baillieres Clin Haematol 6:299-325
4. Bauer TR, Osborne WRA, Kwok WW, Hickstein DD (1994) Expression from leukocyte integrin promoters in viral vectors. Hum Gene Ther 5:709-716
5. Blease RM, Culver KW, Mille AD, Carter CS, Fleisher T, Clerici M, Shearer G, Chang L, Chiang Y, Tolstoshev P, Greenblatt JJ, Rosenberg SA, Klein H, Berger M, Mullen CA, Ramsey WJ, Muul L, Morgan RA, Anderson WF (1995) T Lymphocyte-directed gene therapy for ADA SCID: initial trial results after 4 years. Science 270:475-480
6. Bohinski RJ, Huffman JA, Whitsett JA, Lattier DL (1993) Cis- active elements controlling lung cell-specific expression of human pulmonary surfactant protein B gene. J Biol Chem 268:11160-11166
7. Boothman DA, Lee IW, Sahijdak WM (1994) Isolation of an X-ray-responsive element in the promoter region of tissue-type plasminogen activator: potential uses of X-ray-responsive elements for gene therapy. Radiat Res 138 [Suppl 1]:68-71
8. Bordignon C, Notarangelo LD, Nobili N, Ferrari G, Casorati G, Panina P, Maazzolaari E, Maggioni D, Rossi C, Servida P, Ugazio AG, Mavilio F (1995) Gene therapy in peripheral blood lymphocytes and bone marrow for ADA immunodeficient patients. Science 270:470-475
9. Buchschacher GL, Freed EO, Panganiban AT (1992) Cells induced to express a human immunodeficiency virus type 1 envelope gene mutant inhibit the spread of wild-type virus. Hum Gene Ther 3:391-397
10. Buchschacher GL, Panganiban AT (1992) Human immunodeficiency virus vectors for inducible expression of foreign genes. J Virol 66:2731-2739
11. Burdon T, Sankaran L, Wall RJ, Spencer M, Hennighausen L (1991) Expression of a whey acidic protein transgene during mammary development. J Biol Chem 266:6909-6914
12. Bushman F (1995) Targeting retroviral integration. Science 267:1443-1444
13. Calenda V, Leissner P, Sorg T, Leroy P, Marigliano M, Touraine JL, Sanhadji K, Pavirani A, Mehtali M (1994) Gene therapy for HIV infection. Gene Ther 2:589
14. + cells harboring a human immunodeficiency virus-inducible suicide gene prevents viral spread in an infected population. Proc Natl Acad Sci USA 89:182-186
15. Chang CD, Takeda T, Mukai H, Shuntoh H, Kuno T, Tanaka C (1992) Molecular cloning and characterization of the promoter region of the calcineurin A alpha gene. Biochem J 288:801-805
16. Chen S-Y, Bagley J, Marasco WA (1994) Intracellular antibodies as a new class of therapeutic molecules for gene therapy. Hum Gene Ther 5:595-601
17. Collins FS (1992) Cystic fibrosis: molecular biology and therapeutic implications. Science 256:774-779
18. Cornwell RD, Gollahon KA, Hickstein D D (1993) Description of the leukocyte function-associated antigen 1 (LFA-1 or CD11a) promoter. Proc Natl Acad Sci USA 90:4221-4225
19. Culig Z, Hobisch A, Cronauer MV, Radmayer C, Trapman J, Hittmair A, Bartsch G, Klocker H (1994) Androgen receptor activation in prostatic tumor cell lines by insulin-like growth factor-I, keratinocyte growth factor, and epidermal growth factor. Cancer Res 54:5474-5478
20. Dai Y, Roman M, Naviauz RK, Verma IM (1992) Gene therapy via primary myoblasts: long-term expression of factor XI protein following transplantation in vivo. Proc Natl Acad Sci USA 89:10892-10895
21. Dale TC, Krnacik MJ, Schmidhauser C, Yang C L-Q, Bissel MJ, Rosen JM (1992) High-level expression of the rat whey acidic protein gene is mediated by elements in the promoter and 3′ untranslated region. Mol Cell Biol 12:905-914
22. Dillon N, Grosveld F (1993) Transcriptional regulation of multigene loci. Trends Genet 9:134-137
23. Dunkley MG, Wells DJ, Walsh FS, Dickson G (1993) Direct retroviral-mediated transfer of a dystrophin minigene into mdx mouse muscle in vivo. Hum Mol Genet 2:717-723
24. Einerhand MPW, Antoniou M, Zolotukhin S, Muzyczka N, Berns KI, Grosveld F, Valerio D (1995) Regulated high-level human β-globin gene expression in erythroid cells following recombinant adeno-associated virus-mediated gene transfer. Gene Ther 2:336-343
25. Engelhardt JF, Zepeda M, Cohn JA, Yankaskas JR, Wilson JM (1994) Expression of the cystic fibrosis gene in adult human lung. J Clin Invest 93:737-749
26. Ferkol T, Lindberg GL, Chen J, Perales JC, Crawford DR, Ratnoff OD, Hanson RW (1993) Regulation of the phosphoenolpyruvate carobxykinase/human factor IX gene introduced into the livers of adult rats by receptor-mediated gene transfer. FASEB J 7:1081-1091
27. Ferrari G, Salvatori G, Rossi C, Cossu G, Mavilio F (1995) A retroviral vector containing a muscle-specific enhancer drives gene expression only in differentiated muscle fibers. Hum Gene Ther 6:733-742
28. Friedmann T, Yee J-K (1995) Pseudotyped retroviral vectors for studies of human gene therapy. Nature Med 1:275-277
29. Garver RI, Goldsmith KT, Rodu B, Hu P-C, Sorscher EJ, Curiel DT (1994) Strategy for achieving selective killing of carcinomas. Gene Ther 1:46-50
30. Gazit G, Kane SE, Nichols P, Lee AS (1995) Use of the stress- inducible grp78/BiP promoter in targeting high level gene expression in fibrosarcoma in vivo. Cancer Res 55:1660-1663
31. Grosveld F, Blom van Assendelft G, Greaves DR, Kollias G (1987) Position-independent, high level expression of the human β-globin gene in transgenic mice. Cell 51:975-985
32. Günzburg WH, Salmons B (1992) Factors controlling the expression of mouse mammary tumour virus. Biochem J 283:625-632
33. Hafenrichter DG, Ponder KP, Rettinger SD, Kennedy SC, Wu X, Saylors RS, Flye MW (1994) Liver-directed gene therapy: evaluation of liver specific promoter elements. J Surg Res 56:510-517
34. Hallahan DE, Mauceri HJ, Seung LP, Dunphy EJ, Wayne JD, Hanna NN, Toledano A, Hellman S, Kufe DW, Weichselbaum RR (1995) Spatial and temporal control of gene therapy using ionizing radiation. Nature Med 1:786-791
35. Harris JD, Gutierrez AA, Hurst HC, Sikora K, Lemoine NR (1994) Gene therapy for cancer using tumour-specific prodrug activation. Gene Ther 1:170-175
36. Harrison GS, Long CJ, Curiel TJ, Maxwell F, Maxwell IH (1992) Inhibition of human immunodeficiency virus-1 production resulting from transduction with a retrovirus containing an HIV-regulated diphteria toxin A chain gene. Hum Gene Ther 3:461-469
37. Hatzoglou M, Bosch F, Park EA, Hanson RW (1991) Hormonal control of interacting promoters introduced into cells by retroviruses. J Biol Chem 266:8416-8425
38. Hatzoglou M, Lamers W, Bosch F, Wynshaw-Boris A, Clapp DW, Hanson RW (1990) Hepatic gene transfer in animals using retrovirus containing the promoter from the gene for phosphoenolpyruvate carboxykinase. J Biol Chem 265:17285-17293
39. Hatzoglou M, Park E, Wynshaw-Boris A, Kaung H-L C, Hanson RW (1988) Hormonal regulation of chimeric genes containing the phosphoenolpyruvate carboxykinase promoter regulatory region in hepatoma cells infected by murine retroviruses. J Biol Chem 263:17798-17808
40. Hickstein DD, Baker DM, Gollahon KA, Back AL (1992) Identification of the promoter of the myelomonocytic leukocyte integrin CD11b. Proc Natl Acad Sci USA 89:2105-2109
41. Hollywood DP, Hurst HC (1993) A novel transcription factor, OB2-1, is required for overexpression of the oncogene c-erb-2 in mammary tumor lines. EMBO J 12:2369-2375
42. Huber BE, Richards CA, Krenitsky TA (1991) Retroviral-mediated gene therapy for the treatment of hepatocellular carcinoma: an innovative approach for cancer therapy. Proc Natl Acad Sci USA 88:8039-8043
43. Ido A, Nakata K, Kato Y, Nakao K, Murata K, Fujita M, Ishii N, Tamaoki T, Shiku H, Nagataki S (1995) Gene therapy for hepatoma cells using a retrovirus vector carrying herpes simplex virus thymidine kinase gene under the control of human α-fetoprotein gene promoter. Cancer Res 55:3105-3109
44. Karlsson S, Papayannopoulou T, Schweiger SG, Stamatoyannopoulos G, Nienhuis AW (1987) Retroviral mediated transfer of genomic globin genes leads to regulated production of RNA and protein. Proc Natl Acad Sci USA 84:2411-2415
45. Karpati G (1995) Possible in vivo gene therapy of skeletal muscle in Duchenne muscular dystrophy. Gene Ther 2:583-584
46. Kasahara N, Dozy AM, Kan YW (1994) Tissue-specific targeting of retroviral vectors through ligand-receptor interactions. Science 266:1373-1376
47. Kohno K, Sato S-I, Takano H, Matsuo K-I, Kuwano M (1989) The direct activation of human multidrug resistance gene (MDR1) by anticancer agents. Biochem Biophys Res Comm 165:1415-1421
48. Korner A, Pawalek J (1982) Mammalian tyrosinase catalyzes three reactions in the biosynthesis of melanin. Science 217:1163-1165
49. Kumagai T, Tanio Y, Osaki T, Horai T, Kishimoto T (1995) Gene therapy for small cell lung cancer cells overexpressing myc family oncogenes by tumor-specific expression of the herpes simplex virus thymidine kinase gene. Gene Ther 2:681
50. Kurabayashi M, Komuro I, Shibasaki Y, Tsuchimochi H, Takaku F, Yazaki Y (1990) Functional identification of the transcriptional regulatory elements within the promoter region of the human ventricular myosin alkali light chain. J Biol Chem 265:19271-19278
51. Liem SE, Ramezani A, Li X, Joshi S (1993) The development and testing of retroviral vectors expressing trans-dominant mutants of HIV-1 proteins to confer anti-HIV-1 resistance. Hum Gene Ther 4:625-634
52. Maxwell IH, Glode LM, Maxwell F (1991) Expression of the diphteria toxin A-chain coding sequence under the control of promoters and enhancers from immunoglobulin genes as a means of directing toxicity to B-lymphoid cells. Cancer Res 51:4299-4304
53. Mc Grane M, De Vente J, Yun J, Bloom J, Park E, Wynshaw- Boris A, Wagner T, Rottman FM, Hanson RW (1988) Tissue- specific expression and dietary regulation of chimeric posphoenolpyruvate carboxykinase/bovine growth hormone gene in transgenic mice. J Biol Chem 263:11443-11451
54. Novak U, Harris EAS, Forrester W, Groudin M, Gelinas R (1990) High-level β-globin expression after retroviral transfer of locus activation region-containing human β-globin gene derivatives into murine erythroleukemia cells. Proc Natl Acad Sci USA 87:3386-3390
55. Osaki T, Tanio Y, Tachibana I, Hosoe S, Kumagai T, Kawase I, Oikawa S, Kishimoto T (1994) Gene therapy for carcinoembryonic antigen-producing human lung cancer cells by cell type-specific expression of herpes simplex virus thymidine kinase gene. Cancer Res 54:5258-5261
56. Palmer TD, Rosman GJ, Osborne GRA, Miller AD (1991) Genetically modified skin fibroblasts persist long after transplantation by gradually inactivate introduced genes. Proc Natl Acad Sci USA 88:1330-1334
57. Pantaleo G, Graziosi C, Fauci AS (1993) The immunopathogenesis of human immunodeficiency virus infection. New Engl J Med 328:327-335
58. Partridge T (1994) Skeletal muscle as a target for gene therapy. Gene Ther 1:77-79
59. Ponder KP, Dunbar RP, Wilson DR, Darlington GJ, Woo SL (1991) Evaluation of relative promoter strength in primary hepatocytes using optimized lipofectin. Hum Gene Ther 2:41-52
60. Richards CA, Austin EA, Huber BE (1995) Transcriptional regulatory sequences of carcinoembryonic antigen: identification and use with cytosine deaminase for tumor-specific gene therapy. Hum Gene Ther 6:881-895
61. Richards CA, Huber BE (1993) Generation of transgenic model for retrovirus-mediated gene therapy for hepatocellular carcinoma is thwarted by the lack of transgene expression. Hum Gene Ther 4:143-150
62. Riordan JR, Rommens JM, Kerm B-S, Alon N, Rozmahel R, Grzelczak Z, Zielenski J, Lok S, Plavsik N, Chou J-L, Drumm ML, Ianuzzi MC, Collins FS, Tsui LC (1989) Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA. Science 245:1066-1073
63. Salmons B, Günzburg WH (1993) Targeting of retroviral vectors for gene therapy. Hum Gene Ther 4:129-141
64. Sauerwald A, Hoesche C, Oschwald R, Kilimann MW (1990) The 5′-flanking region of the synapsin I gene. A G+C-rich, TATA-and CAAT-less, phylogenetically conserved sequence with cell type-specific promoter function. J Biol Chem 265:14932-14937
65. Schmitt-Ney M, Doppler W, Ball RK, Groner B (1991) β-Casein gene promoter activity is regulated by the hormone-mediated relief of transcriptional repression and a mammary-gland- specific nuclear factor. Mol Cell Biol 11:3745-3755
66. Schrewe H, Thompson J, Bona M, Hefta LJ, Maruya A, Hassauer M, Shively JE, von Kleist S, Zimmermann W (1990) Cloning of the complete gene for carcinoembryonic antigen: analysis of its promoter indicates a region conveying cell type- specific expression. Mol Cell Biol 10:2738-2748
67. Shelley CS, Arnaout MA (1991) The promoter of the CD11b gene directs myeloid-specific and developmentally regulated expression. Proc Natl Acad Sci USA 88:10525-10529
68. Smith MJ, Rousculp MD, Goldsmith KT, Curiel DT, Garver RI (1994) Surfactant protein A-directed toxin gene kills lung cancer cells in vitro. Hum Gene Ther 5:29-35
69. Smythe JA, Sun D, Thomson M, Markham PD, Reitz MS, Gallo RC, Lisziewicz J (1994) A Rev-inducible mutant gag gene stably transferred into T-lymphocytes: an approach to gene therapy against human immunodeficiency virus type 1 infection. Proc Natl Acad Sci USA 91:3657-3661
70. Sparmann G, Walther W, Günzburg WH, Uckert W, Salmons B (1994) Conditional expression of human TNF-α: a system for inducible cytotoxicity. Int J Cancer 59:103-107
71. Stein U, Walther W, Wunderlich V (1994) Point mutations in the mdr1 promoter of human osteosarcomas are associated with in vitro responsiveness to multidrug resistance relevant drugs. Eur J Cancer 30:1541-1545
72. Strauss M (1994) Liver-directed gene therapy: prospects and problems. Gene Ther 1:156-164
73. Thompson JA, Grunert F, Zimmermann W (1991) Carcinoembryonic antigen gene family: molecular biology and clinical perspectives. J Clin Lab Anal 5:344-366
74. Venkatesh LK, Arens MQ, Subramanian T, Chinnadurai G (1990) Selective induction of toxicity to human cells expressing human immunodeficiency virus type 1 Tat by a conditionany cytotoxic adenovirus vector. Proc Natl Acad Sci USA 87:8746-8750
75. Vile RG, Hart IR (1993) In vitro and in vivo targeting of gene expression to melanoma cells. Cancer Res 53:962-967
76. Vile RG, Nelson JA. Castleden S, Chong H, Hurt IR (1994) Systemic gene therapy of murine melanoma using tissue specific expression of the HSV-tk gene involves an immune component. Cancer Res 54:6228-6234
77. Vile R, Miller N, Chemjovsky Y, Hart IR (1994) A comparison of the properties of different retroviral vectors containing the murine tyrosinase promoter to achieve transcriptionally targeted expression of the HSVtk or IL-2 genes. Gene Ther 1:307-316
78. Walsh CE, Liu JM, Xiao X, Young NS, Nienhuis AW, Samulski RJ (1992) Regulated high level expression of a human γ- globin gene introduced into erythroid cells by an adeno-associated virus vector. Proc Natl Acad Sci USA 89:7257-7261
79. + lymphocyte-derived cell lines conferred by using retroviral vectors expressing an HIV-1 RNA- specific ribozyme. J Virol 65:5531-5534
80. Whitsett JA, Dey CR, Stripp BR, Wikenheiser KA, Clark JC, Wert SE, Gregory RJ, Smith AE, Cohn JA, Wilson JM, Engelhardt J (1992) Human cystic fibrosis transmembrane conductance regulator directed to respiratory epithelial cell of transgenic mice. Nature Genet 2:13-20
81. Williams GT, Morimoto RI (1990) Maximal stress-induced transcription from the human HSP70 promoter requires interactions with the basal promoter elements independent of the rotational alignment. Mol Cell Biol 10:3125-3136
82. Wolff JA, Malone RW, Williams P, Chong W, Acsadi G, Jani A, Feigner PL (1990) Direct gene transfer into mouse muscle in vivo. Science 247:1465-1468